MRIGlobal Expand Infectious Disease Surveillance and Diagnostics.
In 2019, the Infectious Diseases and Clinical Diagnostics programs being managed off-site were transitioned to our Kansas City headquarters, moving into the newly renovated Diagnostics Center of Excellence and CLIA laboratory space. This laboratory space was modernized to accommodate our current programs, while providing the opportunity to grow our client base in this growing market area. Since then, our work in Infectious Disease and Clinical Diagnostics has expanded significantly, with the start of several major programs. In addition, the number of people working on those programs has increased from 10 to nearly 50 scientists. Because our physical laboratory footprint had remained the same, this market growth has challenged us with competing needs laboratory space.
Recently, we renovated what had been unused office space into new laboratory space for the Life Sciences Resource Center. With work having been onboarded in early July, this investment in laboratory space increases our ability to do more work, which will be performed by the Infectious Diseases Surveillance and Diagnostics (IDSD) and Clinical Diagnostics Testing and Evaluation (CDTE) capability groups. This new laboratory will decrease bottlenecks for various programs and allow us to incorporate more programs simultaneously, maintaining and even growing expectations with our current clients and offering them more space for their projects and instrumentation.
By having another modern and inviting laboratory similar to those in our current Diagnostics Center of Excellence and CLIA laboratory, we will accommodate work for customers that include commercial clients and the US government, while having another space to demonstrate our capabilities to clients. Housing this new lab near the Diagnostics Center for Excellence and CLIA laboratories also allows us to group like sciences together. While new construction for laboratory space can run anywhere from $600-800 per square foot, this lab has been renovated for half that, providing a significant value for our customers.
Getting started with MRIGlobal
Contact MRIGlobal to further understand our work in infectious diseases. We offer a broad portfolio of infectious disease testing assays and capabilities across diagnostic disciplines, from screening and diagnosis to genotyping, therapy, and monitoring. Those seeking analysis of infectious disease tests can trust in our breadth of experience and knowledge – not just on the subject matter, but FDA protocols as well. As a not-for-profit contract research organization, we have proven ourselves as an objective partner driven to make our clients’ products more successful. We specialize in defense, human health, pharmaceutical sciences, in-vitro diagnostics, energy, agriculture, and global health.
To learn more about the work we’ve done or how we can help you, contact us today. If you are part of an agency, business, or academic institution seeking assistance with a project, use our Project Quote Tool to get started.
Sign up for our newsletter
Sign up for the MRIGlobal newsletter! It’s the best way to get the latest updates in the world of applied scientific engineering research delivered directly to your inbox.